Secane, PA, United States of America

Vincent Gasbarro

This inventor holds 1 USPTO granted patent. Top assignee: Jpmorgan Chase Bank, N.a.. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vincent Gasbarro: Innovator in Asset Management Technology

Introduction

Vincent Gasbarro is a notable inventor based in Secane, PA (US). He has made significant contributions to the field of asset management through his innovative patent. His work focuses on the management of asset or obligation-backed virtual receipts on a distributed system.

Latest Patents

Vincent holds a patent for "Systems and methods for management of asset or obligation-backed virtual receipts on a distributed system." This patent outlines a method for managing virtual receipts that are tied to underlying assets. The process involves receiving confirmation of a deposit, obtaining authorization to issue a virtual receipt, and executing the issuance by writing the transaction to a distributed ledger. This innovative approach enhances the efficiency and security of asset management.

Career Highlights

Vincent Gasbarro is currently employed at JPMorgan Chase Bank, N.A. His role at the bank allows him to apply his expertise in financial technology and asset management. With a focus on innovation, he continues to contribute to advancements in the banking sector.

Collaborations

Vincent has collaborated with notable colleagues such as Franklin Bi and Christine Moy. Their combined efforts in the field of asset management technology have led to significant advancements and innovations.

Conclusion

Vincent Gasbarro is a pioneering inventor whose work in asset management technology is shaping the future of financial transactions. His patent and contributions to JPMorgan Chase Bank, N.A. highlight his commitment to innovation in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…